Local treatment of experimental Pseudomonas aeruginosa osteomyelitis with a biodegradable dilactide polymer releasing ciprofloxacin

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 7, 2008, Pages 2335-2339

  Kanellakopoulou, Kyriaki ^a,e   Thivaios, George C ^b   Kolia, Maria ^a,b   Dontas, Ismini ^a   Nakopoulou, Lydia ^a   Dounis, Eleftherios ^b   Giamarellos Bourboulis, Evangelos J ^a   Andreopoulos, Andreas ^c   Karagiannakos, Panayotis ^a,d   Giamarellou, Helen ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b LAIKO GENERAL HOSPITAL   (Greece)

^c National Polytechnic School   (Greece)

^d BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^e NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; POLYLACTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GROWTH; BONE RADIOGRAPHY; CANCELLOUS BONE; CONTROLLED STUDY; DRUG IMPLANTATION; EXPERIMENTAL INFECTION; HISTOPATHOLOGY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OSTEOMYELITIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RABBIT; TIBIA; WEIGHT REDUCTION;

ABSORBABLE IMPLANTS; ANIMALS; ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DISEASE MODELS, ANIMAL; DRUG IMPLANTS; HUMANS; MALE; OSTEOMYELITIS; POLYESTERS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RABBITS; TIBIA;

EID: 46449139057     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01360-07     Document Type: Article

References (19)

1. Dutt, M., and G. K. Khuller. 2001. Liposomes and PLG microparticles as sustained release antitubercular drug carriers: an in vitro-in vivo study. Int. J. Antimicrob. Agents 18:245-252.
2. Galanakis, N., H. Giamarellou, T. Moussas, and E. Dounis. 1997. Chronic osteomyelitis caused by multi-resistant gram(-) bacteria: evaluation of treatment with newer quinolones after prolonged follow-up. J. Antimicrob. Chemother. 39:241-246.
3. Gürsel, I., F. Korkusuz, F. Türesin, G. Alaeddinoǧlu, and V. Harici. 2001. In vivo application of biodegradable controlled antibiotic release systems for the treatment of implant-related osteomyelitis. Biomaterials 22:73-80.
4. Haas, D. W., and M. P. McAndrew. 1996. Bacterial osteomyelitis in adults: evolving considerations in diagnosis and treatment. Am. J. Med. 101:550-561.
5. Hansen, G. T., X. Zhao, K. Drlica, and J. M. Blondeau. 2006. Mutant prevention concentration for ciprofloxacin and levofloxacin with Pseudomonas aeruginosa. Int. J. Antimicrob. Agents 27:120-124.
6. Humphrey, S. J., S. Mehta, A. V. Seaber, and T. P. Vail. 1998. Pharmacokinetics of a degradable drug delivery system in bone. Clin. Orthop. 349: 218-224.
7. Jain, A. K., and R. Panchangula. 2000. Skeletal drug delivery systems. Int. J. Pharm. 206:1-12.
8. Kanellakopoulou, K., N. Galanakis, E. J. Giamarellos-Bourboulis, C. Ritiotis, K. Papakostas, A. Andreopoulos, E. Dounis, P. Karagianakos, and H. Giamarellou. 2000. Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a biodegradable system of lactic acid polymer releasing pefloxacin. J. Antimicrob. Chemother. 46:311-314.
9. Kanellakopoulou, K., and E. J. Giamarellos-Bourboulis. 2000. Carrier systems for the local delivery of antibiotics in bone infections. Drugs 59:1223-1232.
10. Kanellakopoulou, K., M. Kolia, A. Anastassiadis, T. Korakis, E. J. Giamarellos-Bourboulis, A. Andreopoulos, E. Dounis, and H. Giamarellou. 1999. Lactic acid polymers as biodegradable carriers of fluoroquinolones: an in vitro study. Antimicrob. Agents Chemother. 43:714-716.
11. Khalil, H., R. J. Williams, G. Stenbeck, B. Henderson, S. Meghji, and S. P. Nair, 2007. Invasion of bone cells by Staphylococcus epidermidis. Microbes Infect. 9:460-465.
12. Kumar Naraharisetti, P., H. Lee, Y. C. Fu, D. J. Lee, and C. H. Wang. 2006. In vitro and in vivo release of gentamicin from biodegradable discs. J. Biomed. Mater. Res. B Appl. Biomater. 77:329-337.
13. Lazarettos, J., N. Efstathopoulos, P. J. Papagelopoulos, O. Savvidou, K. Kanellakopoulou, H. Giamarellou, E. J. Giamarellos-Bourboulis, V. Nikolaou, A. Kapranou, A. Papalois, and G. Papachristou. 2004. A bioresorbable calcium phosphate delivery system with teicoplanin for treating MRSA osteomyelitis. Clin. Orthop. 423:253-258.
14. Mader, J. T., M. E. Shirtliff, S. C. Bergquist, and J. Calhoun. 1999. Antimicrobial treatment of chronic osteomyelitis. Clin. Orthop. 360:47-65.
15. Mäkinen, T. J., M. Veiranto, P. Lankinen, N. Moritz, J. Jalava, P. Tormala, and H. T. Aro. 2005. In vitro and in vivo release of ciprofloxacin from osteoconductive bone defect filler. J. Antimicrob. Chemother. 56:1063-1068.
16. Nelson, D. R., T. B. Buxton, Q. N. Luu, J. P. Rissing, and J. P. 1990. The promotional effect of bone wax on experimental Staphylococcus aureus osteomyelitis. J. Thorac. Cardiovasc. Surg. 99:977-980.
17. Norden, C. W., and E. Kennedy. 1970. Experimental osteomyelitis: a description of the model. J. Infect. Dis. 122:410-418.
18. Patterson, A. L., R. H. Galloway, J. C. Baumgartner, and I. S. Barsoum. 1993. Development of chronic mandibular osteomyelitis in a miniswine model. J. Oral Maxillofac. Surg. 51:1358-1362.
19. Wang, G., S. J. Liu, S. W. Ueng, and E. C. Chan. 2004. The release of cefazolin and gentamicin from biodegradable PLA/PGA beads. Int. J. Pharm. 273:203-212.